Dr. Jeffrey Philip Lahrmann, MD

Dr. Lahrmann practices at Hartford Healthcare Medical Group Primary Care Vernon - HOPD in Vernon, Connecticut.

Dr. Lahrmann's NPI, 1851770861, was assigned on May 22, 2015. Dr. Lahrmann holds Connecticut license 1.062844-RES.

Dr. Lahrmann's primary practice is Hartford Healthcare Medical Group Primary Care Vernon - HOPD, at 35 Talcottville Rd, Vernon, CT 06066.

Dr. Lahrmann's primary practice is Hartford Healthcare Medical Group Primary Care Vernon - HOPD in Vernon, Connecticut. Dr. Lahrmann is also affiliated with Hartford Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Lahrmann to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account. Dr. Lahrmann's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lahrmann practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lahrmann's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Lahrmann's licenses on file in 3 states: Connecticut, Michigan and Pennsylvania.

CMS data shows 224 Medicare services from Dr. Lahrmann across 4 procedure codes in 2024, for 172 Medicare patients. Medicare paid $22,930 for them. Every service was in an office.

CMS counts 172 Medicare patients who saw Dr. Lahrmann in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lahrmann's median patient age at 72, with 46% women.

In 2024, Dr. Lahrmann wrote 2,405 Medicare Part D claims for 525 patients. 84% of them were for generic drugs. CMS names the drug for 2,247 of them, across 31 drugs with 11 or more claims each, at $1,711,854 in total drug cost. In 2023, CMS named 1,428 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Lahrmann for performance year 2024, reported as part of a group. Dr. Lahrmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of skin biopsy by Dr. Lahrmann, more than 63% of the clinicians it reports for that procedure.

CMS Open Payments shows 185 general payments to Dr. Lahrmann from 29 drug and device companies from 2016 to 2025. Grants make up the largest share, 47% of the total. Medtronic USA, Inc. paid the most, $10,805.